Arkansas Supreme Court reverses billion-dollar Risperdal case
The Arkansas Supreme Court today reversed the $1.2 billion verdict for the state of Arkansas against two pharmaceutical companies for billing Medicaid for off-label use of the antipsychotic drug Risperdal.